{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:07:43Z","timestamp":1793768863342,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.radonc.2022.11.025","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:36:27Z","timestamp":1669901787000},"page":"109436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2\u00a0N1 nasopharyngeal carcinoma: A multicenter retrospective study"],"prefix":"10.1016","volume":"178","author":[{"given":"Yu-Jun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Zhu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Juan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Ping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Chun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Rong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Chang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Gao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ji","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.11.025_b0005","unstructured":"National Comprehensive Cancer Network. Head and neck cancers,version 2.2022. Available at: https:\/\/wwwnccnorg\/guidelines\/guidelines-detail?category=1&id=1437."},{"key":"10.1016\/j.radonc.2022.11.025_b0010","doi-asserted-by":"crossref","unstructured":"Li XY, Chen QY, Sun XS, Liu SL, Yan JJ, Guo SS, et al. Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma. European journal of cancer (Oxford, England : 1990). 2019;110:24-31.","DOI":"10.1016\/j.ejca.2018.10.020"},{"key":"10.1016\/j.radonc.2022.11.025_b0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.radonc.2014.01.011","article-title":"Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin","volume":"110","author":"Lin","year":"2014","journal-title":"Radiother Oncol : J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0020","first-page":"2587","article-title":"Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up","volume":"2015","author":"Zhang","year":"1990","journal-title":"Eur J Cancer (Oxford, England)"},{"key":"10.1016\/j.radonc.2022.11.025_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/jjco\/hyv192","article-title":"Long-term survival of nasopharyngeal carcinoma patients with stage II in intensity-modulated radiation therapy era","volume":"46","author":"Guo","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0030","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/cam4.2785","article-title":"Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: a propensity score matching study","volume":"9","author":"Liu","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2022.11.025_b0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","article-title":"Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone","volume":"82","author":"Su","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.025_b0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2147\/CMAR.S239729","article-title":"Management of chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a review","volume":"12","author":"Wu","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.radonc.2022.11.025_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104520","article-title":"The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma","volume":"101","author":"Pan","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0050","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1007\/s13277-015-4266-5","article-title":"Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study","volume":"37","author":"Su","year":"2016","journal-title":"Tumour Biol : J Int Soc Oncodevelop Biol Med"},{"key":"10.1016\/j.radonc.2022.11.025_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.104490","article-title":"Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: a study based on a phase III randomized clinical trial with 10-year follow-up","volume":"100","author":"Sun","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0060","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/hed.25842","article-title":"High-grade radiologic extra-nodal extension predicts distant metastasis in stage II nasopharyngeal carcinoma","volume":"41","author":"Hu","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2022.11.025_b0065","unstructured":"Amin MB ES, Greene FL, Byrd DR, Brookland R, Washington M, editors. AJCC Cancer Staging Manual. 8th ed. New York : Springer. 2017."},{"key":"10.1016\/j.radonc.2022.11.025_b0070","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2022.11.025_b0075","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1097\/MD.0000000000000808","article-title":"Suggestions for lymph node classification of UICC\/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"94","author":"Guo","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.radonc.2022.11.025_b0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2012.09.003","article-title":"Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy","volume":"86","author":"Li","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.025_b0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/01945998211008887","article-title":"Prognostic significance of radiologic extranodal extension in nasopharyngeal cancer","volume":"166","author":"Karakurt Ery\u0131lmaz","year":"2022","journal-title":"Otolaryngol\u2013Head Neck Surg : Off J Am Acad Otolaryngol-Head Neck Surg"},{"key":"10.1016\/j.radonc.2022.11.025_b0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jmri.27339","article-title":"Prognostic value of nodal matting on MRI in nasopharyngeal carcinoma patients","volume":"53","author":"Ma","year":"2021","journal-title":"J Magn Reson Imaging : JMRI"},{"key":"10.1016\/j.radonc.2022.11.025_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2018.11.001","article-title":"The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy","volume":"131","author":"Wan","year":"2019","journal-title":"Radiother Oncol : J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0100","doi-asserted-by":"crossref","first-page":"9172585","DOI":"10.1155\/2018\/9172585","article-title":"Quantitative metastatic lymph node regions on magnetic resonance imaging are superior to AJCC N classification for the prognosis of nasopharyngeal carcinoma","volume":"2018","author":"Zhou","year":"2018","journal-title":"J Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0105","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1158\/1078-0432.CCR-08-0271","article-title":"The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging","volume":"14","author":"Mao","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.11.025_b0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.oraloncology.2018.11.007","article-title":"Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx","volume":"88","author":"Ai","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2021.10.018","article-title":"Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort","volume":"165","author":"Chin","year":"2021","journal-title":"Radiother Oncol : J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2019.09.030","article-title":"Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma","volume":"99","author":"Lu","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2021.01.015","article-title":"Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: potential improvement for future editions of N category systems","volume":"157","author":"Mao","year":"2021","journal-title":"Radiother Oncol : J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12874-017-0442-1","article-title":"When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts","volume":"17","author":"Jakobsen","year":"2017","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2022.11.025_b0135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4097\/kjae.2013.64.5.402","article-title":"The prevention and handling of the missing data","volume":"64","author":"Kang","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.radonc.2022.11.025_b0140","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1056\/NEJMoa032260","article-title":"Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma","volume":"350","author":"Lin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.11.025_b0145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein-Barr Virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.11.025_b0150","first-page":"13","article-title":"External validation of a nomogram to predict survival and benefit of concurrent chemoradiation for stage II nasopharyngeal carcinoma","author":"Yip","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2022.11.025_b0155","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.025_b0160","first-page":"2064","article-title":"Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial","volume":"6","author":"Tang","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.radonc.2022.11.025_b0165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(18)30104-9","article-title":"Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial","volume":"19","author":"Tang","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:23:29Z","timestamp":1759123409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022045820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":33,"alternative-id":["S0167814022045820"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.025","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of radiologic extranodal extension in predicting prognosis and chemotherapy benefit for T1-2\u00a0N1 nasopharyngeal carcinoma: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109436"}}